Latest Funding News

Austal Limited has announced a record-breaking $14.2 billion order book, underpinned by strong US and Australian defence contracts, and raised its FY2025 EBIT guidance to at least $80 million.

Vicinity Centres reports a robust third quarter for FY25, driven by strong retailer demand and shopper confidence, highlighted by the successful launch of The Market Pavilion at Chadstone.

Vicinity Centres reports a robust third quarter for FY25, buoyed by record visitation at Chadstone’s new Market Pavilion and strong retail sales growth. The company now expects full-year earnings at the top end of guidance, underpinned by resilient portfolio metrics and strategic asset management.

HMC Capital has unveiled an ambitious plan to grow its assets under management to over $50 billion within the next 3-5 years, supported by strong fundraising and diversified investment verticals. The company’s FY25 outlook remains solid, underpinned by operational growth and strategic initiatives across real estate, digital infrastructure, and energy transition.

BlackRock Investment Management (Australia) Limited has announced an estimated cash distribution of 32.099015 cents per unit for its iShares Core Cash ETF (BILL), with key dates scheduled throughout May 2025.

Foresta Group Holdings’ subsidiary partners with New Zealand’s EECA to explore geothermal steam for its flagship biomass facility, aiming to boost sustainability and efficiency.

Epsilon Healthcare reports ongoing operational challenges post-voluntary administration while unveiling a new pharmacy subsidiary aimed at diversifying revenue streams and rebuilding market confidence.

Spenda Limited has responded to an ASX price query following a notable rise in its share price and trading volume, denying any undisclosed material information while confirming ongoing confidential negotiations for virtual card and funding services.

A shareholder has lodged an application with the Takeovers Panel challenging FBR Limited’s upcoming extraordinary general meeting resolutions related to significant share placements and funding arrangements with Fidelity International.

Enlitic Inc. has been reinstated to trading on the ASX following its announcement of a new equity raise, signaling renewed investor interest in the health technology firm.

Enlitic has signed a binding MoU with GE HealthCare to deliver up to A$50 million in migration services over five years, contingent on a A$10 million equity raise that the company has now initiated.

Papyrus Australia has issued a revised Appendix 4C for the March 2025 quarter, correcting the treatment of $527k in R&D expenditure previously reported as cash payments. This adjustment also impacts prior monthly and quarterly cash flow reports dating back to November 2024.